🧬 Genotropin (HGH) Pfizer GoQuick 12 mg/1.5 ml (36 IU) Injection Pen

Genotropin GoQuick is a ready-to-use prefilled pen containing 12 mg (36 IU) of recombinant human growth hormone, also known as somatropin. Manufactured by Pfizer, this product is designed to deliver growth hormone therapy safely, accurately, and conveniently for both children and adults who require replacement or stimulation of natural growth hormone production. It is administered by subcutaneous injection and must be prescribed by a qualified healthcare professional.

---

What Is Genotropin GoQuick?

Genotropin GoQuick contains somatropin, a laboratory-produced form of human growth hormone that is identical to the natural hormone secreted by the pituitary gland. This hormone plays a crucial role in cell growth, bone development, and overall metabolism. By binding to specific receptors in the body, somatropin promotes protein synthesis, encourages the breakdown of fat for energy, helps preserve lean muscle mass, and improves calcium balance and bone density.

The GoQuick pen is designed for ease of use, combining the powder and solvent in one device that automatically reconstitutes when activated, allowing patients to inject the medicine with minimal preparation.

---

Medical Uses and Indications

Genotropin GoQuick is prescribed for a variety of growth-related conditions. In children, it is used to treat growth failure caused by inadequate secretion of natural growth hormone, Turner syndrome, chronic kidney disease, or Prader–Willi syndrome. It also supports children who were born small for their gestational age and who have not shown normal catch-up growth by around four years of age.

In adults, Genotropin GoQuick is indicated for growth hormone deficiency that may occur as a result of pituitary disorders, hypothalamic disease, surgery, radiation therapy, trauma, or idiopathic causes. It helps restore body composition by increasing muscle mass, reducing fat tissue, and improving physical performance and overall quality of life.

---

How Genotropin Works

Somatropin acts by mimicking the body’s natural growth hormone. It stimulates the growth of bones and cartilage in children and supports tissue repair, protein synthesis, and energy metabolism in adults. By encouraging fat breakdown and glucose regulation, it contributes to healthier body composition and improved vitality. The result is not only physical growth in children but also better metabolic balance and cellular regeneration in adults with growth hormone deficiency.

---

Dosage and Administration

Genotropin GoQuick is injected under the skin (subcutaneously), usually in areas such as the thigh, abdomen, buttock, or upper arm. It is important to rotate injection sites to prevent irritation. The exact dose and frequency are individualized and determined by a physician based on body weight, medical condition, and treatment response.

For children, the usual starting dose ranges between 0.025 mg and 0.035 mg per kilogram of body weight per day. Adults typically begin with a lower dose, around 0.15 mg to 0.30 mg per day, which may be gradually adjusted. The pen delivers the correct dosage automatically, ensuring accuracy and convenience for the patient.

---

Important Precautions

Treatment with Genotropin GoQuick should always be monitored by a healthcare professional. It should not be used in patients with active cancer, tumors, or severe acute illness following surgery or trauma. It is also contraindicated when the growth plates (epiphyses) in bones are closed.

Patients with diabetes, thyroid disorders, or pituitary tumors must be carefully supervised, as the therapy can influence hormonal balance. Those being treated for Prader–Willi syndrome should be observed for breathing difficulties or sleep-related problems, particularly if they are overweight. Pregnant and breastfeeding women should use this medication only if specifically advised by a doctor.

---

Possible Side Effects

Most patients tolerate Genotropin well, but like any medication, side effects can occur. Mild reactions such as redness, pain, or swelling at the injection site are relatively common. Some individuals may experience joint or muscle pain, mild headaches, water retention (edema), or tingling sensations in the hands and feet.

Serious side effects are rare but can include increased pressure inside the skull, changes in vision, or signs of hormone imbalance such as fatigue or weight changes. Allergic reactions are uncommon but require immediate medical attention. Regular medical check-ups and blood tests help ensure safe and effective treatment.

---

Drug Interactions

Genotropin may interact with other medications that influence hormone levels. Corticosteroids can reduce its effectiveness, while insulin or other anti-diabetic drugs may need dosage adjustments. Thyroid hormones, estrogen therapy, and certain anticonvulsant medications can also alter how growth hormone acts in the body. Always inform your doctor about all medicines or supplements you are taking before starting treatment.

---

Composition

Each GoQuick pen contains 12 mg of somatropin (36 IU) dissolved in 1.5 ml of solution. The inactive ingredients include glycine (E640), mannitol (E421), disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate, and water for injection. The formulation is sterile and free from preservatives or pyrogens, ensuring safety and stability.

---

Storage and Handling

Genotropin GoQuick must be stored in a refrigerator between 2 °C and 8 °C (36 °F–46 °F). It should never be frozen. Keep the pen in its original packaging to protect it from light. After the first use, the pen should remain refrigerated and be used within 28 days. Always discard used pens and needles in a proper sharps container, following local regulations for pharmaceutical waste.

---

Monitoring and Follow-Up

Long-term therapy with growth hormone requires regular monitoring by an endocrinologist. Blood tests are used to measure IGF-1 levels, glucose tolerance, and thyroid function to ensure optimal results and safety. Dosages may need periodic adjustment depending on age, response, and changes in body composition.

---

Important Advice for Patients

To achieve the best outcomes with Genotropin GoQuick, patients are encouraged to follow a balanced diet, engage in regular physical activity, and adhere to their prescribed dosing schedule. In individuals with Prader–Willi syndrome, dietary control and weight management are essential. Treatment should never be stopped or modified without consulting the healthcare provider.

---

Summary

Genotropin GoQuick 12 mg/1.5 ml is an advanced, easy-to-use injection pen designed for the precise administration of recombinant human growth hormone. It supports healthy growth in children and restores metabolic balance and vitality in adults with growth hormone deficiency. Manufactured under strict quality standards by Pfizer, it combines biotechnology innovation with patient-friendly design, providing a reliable therapy option under professional medical supervision.

---

SEO Meta Description (for your website)

Genotropin GoQuick 12 mg/1.5 ml by Pfizer — a prefilled growth hormone injection pen containing somatropin for the treatment of growth hormone deficiency in children and adults. Promotes growth, muscle development, and metabolic health. Prescription required.